123 related articles for article (PubMed ID: 37944894)
1. Daily methocinnamox treatment dose-dependently attenuates fentanyl self-administration in rhesus monkeys.
Maguire DR; France CP
Neuropharmacology; 2024 Feb; 243():109777. PubMed ID: 37944894
[TBL] [Abstract][Full Text] [Related]
2. Effects of Daily Methocinnamox Treatment on Fentanyl Self-Administration in Rhesus Monkeys.
Maguire DR; France CP
J Pharmacol Exp Ther; 2022 Aug; 382(2):181-187. PubMed ID: 35643857
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of the Positive-Reinforcing Effects of Ultra-Potent Fentanyl Analogs, Along with Those of Fentanyl and Heroin, During Daily Treatment with Methocinnamox in Rhesus Monkeys.
Gerak LR; France CP
J Pharmacol Exp Ther; 2023 Mar; 384(3):363-371. PubMed ID: 36575032
[TBL] [Abstract][Full Text] [Related]
4. Effects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys.
Maguire DR; Gerak LR; Sanchez JJ; Javors MA; Disney A; Husbands SM; France CP
Neuropsychopharmacology; 2020 Nov; 45(12):1986-1993. PubMed ID: 32375158
[TBL] [Abstract][Full Text] [Related]
5.
Hiranita T; Ho NP; France CP
J Pharmacol Exp Ther; 2024 Feb; ():. PubMed ID: 38409115
[TBL] [Abstract][Full Text] [Related]
6. Long-Lasting Effects of Methocinnamox on Opioid Self-Administration in Rhesus Monkeys.
Maguire DR; Gerak LR; Woods JH; Husbands SM; Disney A; France CP
J Pharmacol Exp Ther; 2019 Jan; 368(1):88-99. PubMed ID: 30401680
[TBL] [Abstract][Full Text] [Related]
7. Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel
Gerak LR; Maguire DR; Woods JH; Husbands SM; Disney A; France CP
J Pharmacol Exp Ther; 2019 Feb; 368(2):229-236. PubMed ID: 30463875
[TBL] [Abstract][Full Text] [Related]
8. Methocinnamox (MCAM) antagonizes the behavioral suppressant effects of morphine without impairing delayed matching-to-sample accuracy in rhesus monkeys.
Minervini V; Disney A; Husbands SM; France CP
Psychopharmacology (Berl); 2020 Oct; 237(10):3057-3065. PubMed ID: 32772146
[TBL] [Abstract][Full Text] [Related]
9. Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of
Gerak LR; Minervini V; Latham E; Ghodrati S; Lillis KV; Wooden J; Disney A; Husbands SM; France CP
J Pharmacol Exp Ther; 2019 Nov; 371(2):507-516. PubMed ID: 31439807
[TBL] [Abstract][Full Text] [Related]
10. Methocinnamox Reverses and Prevents Fentanyl-Induced Ventilatory Depression in Rats.
Jimenez VM; Castaneda G; France CP
J Pharmacol Exp Ther; 2021 Apr; 377(1):29-38. PubMed ID: 33431611
[TBL] [Abstract][Full Text] [Related]
11. Behavioral pharmacology of methocinnamox: A potential new treatment for opioid overdose and opioid use disorder.
Maguire DR; France CP
J Exp Anal Behav; 2023 Mar; 119(2):392-406. PubMed ID: 36759567
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the Discriminative Stimulus Effects of Binary Mixtures of
Flynn SM; France CP
J Pharmacol Exp Ther; 2022 Mar; 380(3):171-179. PubMed ID: 34903563
[TBL] [Abstract][Full Text] [Related]
13. Interactions between μ-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration.
Maguire DR; Yang W; France CP
J Pharmacol Exp Ther; 2013 Jun; 345(3):354-62. PubMed ID: 23536317
[TBL] [Abstract][Full Text] [Related]
14. Discriminative stimulus effects of carfentanil in rats discriminating fentanyl: Differential antagonism by naltrexone.
Flynn SM; France CP
Drug Alcohol Depend; 2021 Apr; 221():108599. PubMed ID: 33631547
[TBL] [Abstract][Full Text] [Related]
15. Selective enhancement of fentanyl-induced antinociception by the delta agonist SNC162 but not by ketamine in rhesus monkeys: Further evidence supportive of delta agonists as candidate adjuncts to mu opioid analgesics.
Banks ML; Folk JE; Rice KC; Negus SS
Pharmacol Biochem Behav; 2010 Dec; 97(2):205-12. PubMed ID: 20678514
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive effects of fentanyl and nonopioid drugs in methocinnamox-treated rats.
Ghodrati S; Carey LM; France CP
Drug Alcohol Depend; 2024 Jul; 260():111320. PubMed ID: 38723374
[TBL] [Abstract][Full Text] [Related]
17. Modulation of delta opioid agonist-induced antinociception by repeated morphine pretreatment in rhesus monkeys.
Negus SS; Banks ML; Folk JE; Rice KC
Life Sci; 2010 Mar; 86(11-12):385-92. PubMed ID: 20096291
[TBL] [Abstract][Full Text] [Related]
18. A synthetic opioid vaccine attenuates fentanyl-vs-food choice in male and female rhesus monkeys.
Townsend EA; Bremer PT; Jacob NT; Negus SS; Janda KD; Banks ML
Drug Alcohol Depend; 2021 Jan; 218():108348. PubMed ID: 33268227
[TBL] [Abstract][Full Text] [Related]
19. Micro/kappa opioid interactions in rhesus monkeys: implications for analgesia and abuse liability.
Negus SS; Schrode K; Stevenson GW
Exp Clin Psychopharmacol; 2008 Oct; 16(5):386-99. PubMed ID: 18837635
[TBL] [Abstract][Full Text] [Related]
20. Self-Administration of Fentanyl-Alprazolam Combinations by Rhesus Monkeys Responding under a Progressive-Ratio Schedule.
Berro LF; Zamarripa CA; Rowlett JK
J Pharmacol Exp Ther; 2022 Dec; 383(3):199-207. PubMed ID: 36153004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
